CY1119486T1 - Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο - Google Patents

Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο

Info

Publication number
CY1119486T1
CY1119486T1 CY20171101019T CY171101019T CY1119486T1 CY 1119486 T1 CY1119486 T1 CY 1119486T1 CY 20171101019 T CY20171101019 T CY 20171101019T CY 171101019 T CY171101019 T CY 171101019T CY 1119486 T1 CY1119486 T1 CY 1119486T1
Authority
CY
Cyprus
Prior art keywords
polymer
amin
american
amine
condition
Prior art date
Application number
CY20171101019T
Other languages
Greek (el)
English (en)
Inventor
Steven K. Burke
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of CY1119486T1 publication Critical patent/CY1119486T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY20171101019T 2001-04-18 2017-09-27 Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο CY1119486T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28444501P 2001-04-18 2001-04-18
US30556401P 2001-07-13 2001-07-13
EP02726733A EP1392331B1 (en) 2001-04-18 2002-04-10 Use of colesevelam or sevelamer hydrogen chloride for lowering serum glucose

Publications (1)

Publication Number Publication Date
CY1119486T1 true CY1119486T1 (el) 2018-03-07

Family

ID=26962623

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101019T CY1119486T1 (el) 2001-04-18 2017-09-27 Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο

Country Status (17)

Country Link
US (2) US7229613B2 (enExample)
EP (1) EP1392331B1 (enExample)
JP (2) JP4499363B2 (enExample)
KR (1) KR20040018358A (enExample)
CN (1) CN1511039A (enExample)
AT (1) ATE390927T1 (enExample)
AU (1) AU2002257145B2 (enExample)
BR (1) BRPI0209134B8 (enExample)
CA (1) CA2444046C (enExample)
CY (1) CY1119486T1 (enExample)
DE (1) DE60225908T2 (enExample)
DK (2) DK1392331T3 (enExample)
ES (2) ES2637020T3 (enExample)
MX (1) MXPA03009568A (enExample)
NZ (1) NZ528831A (enExample)
PT (1) PT1923064T (enExample)
WO (1) WO2002085377A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CA2444046C (en) * 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
WO2005092349A1 (ja) * 2004-03-26 2005-10-06 Mitsubishi Pharma Corporation インスリン抵抗性改善剤
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
WO2007027566A2 (en) * 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
JP2009514966A (ja) * 2005-11-08 2009-04-09 ジェンザイム・コーポレーション 高リン血症のためのマグネシウム含有重合体
WO2008005217A2 (en) * 2006-07-05 2008-01-10 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
WO2008062437A2 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
EP2361171A4 (en) * 2008-09-15 2014-11-05 Shasun Chemicals And Drugs Ltd PROCESS FOR PREPARING NETWORKED POLYMERS IN A NON-AQUEOUS SOLUTION
US20110081413A1 (en) * 2009-01-22 2011-04-07 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
US9566299B2 (en) 2013-02-08 2017-02-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
PE20151766A1 (es) * 2013-03-15 2015-12-11 Genzyme Corp Agentes quelantes de precursores de producto final de glicacion avanzada (age)
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
JP6792640B2 (ja) 2016-12-28 2020-11-25 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
EP3698799B1 (en) 2017-10-16 2022-01-26 FUJIFILM Corporation Hyperphosphatemia treatment agent
ES2980624T3 (es) 2021-08-24 2024-10-02 Waterstone Pharmaceuticals Wuhan Co Ltd Polímeros, composiciones y métodos para tratar hiperuricemia
WO2023023938A1 (en) * 2021-08-24 2023-03-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528847A (en) * 1983-10-04 1985-07-16 D. Halmi And Associates, Inc. Flow metering device with recessed pressure taps
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
CA1220896A (en) 1983-11-10 1987-04-21 Susumu Harada Process for producing polymers of monoallylamine
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
JP3507523B2 (ja) 1993-05-12 2004-03-15 積水化学工業株式会社 糖質吸収抑制剤
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5900475A (en) 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
JP4156684B2 (ja) * 1996-03-05 2008-09-24 三菱化学株式会社 高リン血症予防および／または治療剤
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
FR2766195A1 (fr) 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
DK1140185T3 (da) * 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
CA2444046C (en) * 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
US20020198202A1 (en) 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and an antilipemic agent

Also Published As

Publication number Publication date
US20020187121A1 (en) 2002-12-12
EP1392331B1 (en) 2008-04-02
AU2002257145B2 (en) 2005-06-02
BR0209134A (pt) 2004-06-15
KR20040018358A (ko) 2004-03-03
MXPA03009568A (es) 2004-02-12
US7229613B2 (en) 2007-06-12
JP2010090172A (ja) 2010-04-22
ES2637020T3 (es) 2017-10-10
BRPI0209134B1 (pt) 2019-08-27
ES2304437T3 (es) 2008-10-16
DK1392331T3 (da) 2008-06-23
BRPI0209134B8 (pt) 2021-05-25
CA2444046C (en) 2011-06-07
WO2002085377A1 (en) 2002-10-31
DK1923064T3 (en) 2017-10-02
JP4499363B2 (ja) 2010-07-07
DE60225908D1 (de) 2008-05-15
WO2002085377A8 (en) 2002-11-28
NZ528831A (en) 2005-07-29
US20070286841A1 (en) 2007-12-13
CA2444046A1 (en) 2002-10-31
PT1923064T (pt) 2017-08-23
DE60225908T2 (de) 2009-05-14
CN1511039A (zh) 2004-07-07
JP2004535384A (ja) 2004-11-25
ATE390927T1 (de) 2008-04-15
EP1392331A1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
MXPA03009568A (es) Metodo para reducir el nivel de glucosa en el suero.
ATE380553T1 (de) Aminpolymere zur behandlung von gicht und zur senkung des harnsäuregehaltes
MY125874A (en) Use of polyallylamine polymers for the manufacture of a medicament for treating hypercholesterolemia
CA2594215A1 (en) Sustained-release nanoparticle compositions and methods for using the same
ATE287911T1 (de) Verwendung von poly(diallylamin) polymeren
ATE371680T1 (de) Polymerkonjugate
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
ATE316786T1 (de) Behandlung von mukositis
DK1409006T3 (da) Monodispergerede blandinger og fremgangsmåder til behandling af diabetes
ATE359069T1 (de) Therapeutische zusammenstellungen
NO20025627D0 (no) Fremgangsmåter og sammensetninger for å behandle hepatitt C virus
BR0107815A (pt) Derivados aminados de di-hidro-1,3,5-triazina e suas aplicações em terapêutica
ATE183924T1 (de) Cholesterinspiegelsenkendes mittel
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
SE0102147D0 (sv) New methods
TR200800691T2 (tr) Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi.
EP1923064A3 (en) Use of amine polymer for lowering serum glucose
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
WO2004047779A3 (en) Polymers containing quaternary ammonium salts
MY122400A (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
BRPI0507853A (pt) processo para o tratamento de material de fibra e nova composição
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
NO20034453L (no) Anvendelse av CD25-bindende molekyler i steroid-resistente pasienter